Immunic
IMUX
0,79 €
Share price
1.83%
Change (1 day)
-39.30%
Change (1 year)
Categories
Earnings for Immunic (IMUX)
Earnings in 2024 (TTM): -€91.06 Million
According to Immunic's latest financial reports the company's current earnings are N/A. , an increase over its 2023 earnings that were of -€87.32 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Immunic from 2013 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | -€86.29 Million | -1.18% |
| 2023 | -€87.32 Million | 14.68% |
| 2022 | -€76.14 Million | -5.62% |
| 2021 | -€80.67 Million | 87.18% |
| 2020 | -€43.1 Million | 32.24% |
| 2019 | -€32.59 Million | -9.25% |
| 2018 | -€35.91 Million | -22.5% |
| 2017 | -€46.34 Million | 27.6% |
| 2016 | -€36.32 Million | -20.82% |
| 2015 | -€45.87 Million | 9.34% |
| 2014 | -€41.95 Million | 33.05% |
| 2013 | -€31.53 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -€0.13 Billion | 45.73% | 🇺🇸 USA |